<?xml version="1.0" encoding="UTF-8"?>
<p>Even in countries such as Australia, where there is close collaboration between community, government and health practitioners to guide implementation, elimination cannot be guaranteed because many patients remain undiagnosed and/or do not access treatment.
 <xref rid="liv14222-bib-0093" ref-type="ref">93</xref>, 
 <xref rid="liv14222-bib-0097" ref-type="ref">97</xref>, 
 <xref rid="liv14222-bib-0098" ref-type="ref">98</xref> Identification of sufficient numbers of infected patients needing treatment remains a challenge globally; meanwhile, in countries where scale‐up of a viral hepatitis response is pending, demand for viral hepatitis testing and treatment can outstrip available testing and treatment facilities,
 <xref rid="liv14222-bib-0085" ref-type="ref">85</xref> creating bottlenecks within the care cascade leading to losses to follow‐up. High levels of stigma, discrimination, social marginalisation and legal impediments imposed on key populations at risk or infected with viral hepatitis (eg PWID, prisoners, men who have sex with men, sex workers) is a major issue preventing engagement in care and service access
 <xref rid="liv14222-bib-0084" ref-type="ref">84</xref> and in many countries legal protections remain insufficient.
 <xref rid="liv14222-bib-0068" ref-type="ref">68</xref> The impact of regressive policies and laws on the elimination response cannot be underestimated.
</p>
